acetopyrrothine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Jing, C; Lai, Q; Li, L; Li, X; Liu, D; Wang, X; Wei, H; Wu, Y; Yao, X; Ye, B; Yue, K; Zhang, W; Zhou, M; Zhuo, S | 1 |
1 other study(ies) available for acetopyrrothine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Deubiquitinating Enzymes; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Prognosis; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Pyrrolidinones; SOXB1 Transcription Factors; Squamous Cell Carcinoma of Head and Neck; Trans-Activators; Ubiquitination | 2021 |